Immatics NV
NASDAQ:IMTX
Immatics NV
EPS (Diluted)
Immatics NV
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immatics NV
NASDAQ:IMTX
|
EPS (Diluted)
-€1
|
CAGR 3-Years
35%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
EPS (Diluted)
€3
|
CAGR 3-Years
300%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
EPS (Diluted)
-€12
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-45%
|
CAGR 10-Years
N/A
|
|
CureVac NV
NASDAQ:CVAC
|
EPS (Diluted)
-€1
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
EPS (Diluted)
€3
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
18%
|
|
Formycon AG
XETRA:FYB
|
EPS (Diluted)
€4
|
CAGR 3-Years
N/A
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
See Also
What is Immatics NV's EPS (Diluted)?
EPS (Diluted)
-1.2
EUR
Based on the financial report for Dec 31, 2023, Immatics NV's EPS (Diluted) amounts to -1.2 EUR.
What is Immatics NV's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-5%
The average annual EPS (Diluted) growth rates for Immatics NV have been 35% over the past three years , -5% over the past five years .